, Singapore
Logo from IHH Healthcare

IHH unit withdraws IPO application in India

Agilus submitted its  Draft Red Herring Prospectus on 29 September.

Agilus Diagnostics, an indirect subsidiary of IHH Healthcare, has aborted its plan for an IPO in the Securities and Exchange Board of India (SEBI).

In a bourse filing, IHH said its Agilus has received approval to withdraw its Draft Red Herring Prospectus (DRHP) submitted on 29 September for a proposed IPO process through an offer of sale.

IHH cited "commercial conditions" as the reason for the IPO cancellation.

"Agilus would be making the necessary application to SEBI for withdrawal of the said DRHP immediately and may re-file with SEBI again for a proposed IPO in future, subject to applicable laws," IHH said,
 

Follow the link for more news on

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!